Filing Flows › Denali Therapeutics (DNLI) › How it makes money
How Denali Therapeutics (DNLI) makes money
Denali Therapeutics (DNLI) made $17.8M of revenue in the third quarter 2026 (Q3 2026).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $17.8M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $17.8M | — |
| Q2 2026 | $3.6M | — |
From Denali Therapeutics' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Denali Therapeutics make money?
Denali Therapeutics (DNLI) made $17.8M of revenue in the third quarter 2026 (Q3 2026).
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.